Endocrinol Metab.  2016 Dec;31(4):537-546. 10.3803/EnM.2016.31.4.537.

Urinary Albumin Excretion Reflects Cardiovascular Risk in Postmenopausal Women without Diabetes: The 2011 to 2013 Korean National Health and Nutrition Examination Survey

• Ahn HJ
• Moon DS
• Kang DY
• Lee JI
• Kim DY
• Kim JH
• Kim SY
• Bae HY

• KMID: 2373074
• DOI: http://doi.org/10.3803/EnM.2016.31.4.537

Abstract

BACKGROUND
The objective of the current study was to determine whether there was an association between urinary albumin excretion and cardiovascular disease (CVD) risk by estimating the Framingham Risk Score (FRS) in postmenopausal women without diabetes.
METHODS
This study was based on data from the Korea National Health and Nutrition Examination Survey, which was conducted by the Korean Ministry of Health and Welfare in 2011 to 2013. Data on 2,316 postmenopausal women from a total of 24,594 participants was included in the analysis.
RESULTS
The mean FRS was significantly different in each of the urinary albumin to creatinine ratio (UACR) subgroups, and it increased with UACR. The FRS was 12.69±0.12 in the optimal group, 14.30±0.19 in the intermediate normal group, 14.62±0.26 in the high normal group, and 15.86±0.36 in the microalbuminuria group. After fully adjusting for potential confounding factors, high normal levels and microalbuminuria were significantly associated with the highest tertile of FRS ([odds ratio (OR), 1.642; 95% confidence interval (CI), 1.124 to 2.400] and [OR, 3.385; 95% CI, 2.088 to 5.488], respectively) compared with the optimal subgroup. High normal levels and microalbuminuria were also significantly associated with a ≥10% 10-year risk of CVD ([OR, 1.853; 95% CI, 1.122 to 3.060] and [OR, 2.831; 95% CI, 1.327 to 6.037], respectively) after adjusting for potential confounding covariates.
CONCLUSION
Urinary albumin excretion reflects CVD risk in postmenopausal women without diabetes, and high normal levels and microalbuminuria were independently associated with a higher risk of CVD.

Keyword

Urinary albumin excretion; Cardiovascular risk; Postmenopause

MeSH Terms

Cardiovascular Diseases
Creatinine
Female
Humans
Korea
Nutrition Surveys*
Postmenopause
Creatinine

Reference

1. Basi S, Fesler P, Mimran A, Lewis JB. Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander? Diabetes Care. 2008; 31(Suppl 2):S194–S201. PMID: 18227485.

2. Rachmani R, Levi Z, Lidar M, Slavachevski I, Half-Onn E, Ravid M. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Diabetes Res Clin Pract. 2000; 49:187–194. PMID: 10963831.

3. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol. 2006; 17:2100–2105. PMID: 16825327.

4. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001; 249:519–526. PMID: 11422658.

5. Kweon SS, Shin MH, Choi JS, Nam HS, Lee YH, Park KS, et al. Prevalence of albuminuria and associated cardiovascular risk factors: a community cohort in Namwon City, Korea. Diabetes Res Clin Pract. 2012; 97:492–498. PMID: 22682946.

6. Ma H, Lin H, Hofman A, Hu Y, Li X, He W, et al. Low-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng Study. Atherosclerosis. 2013; 228:237–242. PMID: 23453351.

7. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001; 286:421–426. PMID: 11466120.

8. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002; 106:1777–1782. PMID: 12356629.

9. Lieb W, Mayer B, Stritzke J, Doering A, Hense HW, Loewel H, et al. Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant. 2006; 21:2780–2787. PMID: 16880179.

10. Solbu MD, Kronborg J, Jenssen TG, Njolstad I, Lochen ML, Mathiesen EB, et al. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis. 2009; 204:503–508. PMID: 19091314.

11. Jorgensen L, Jenssen T, Heuch I, Jacobsen BK. The combined effect of albuminuria and inflammation on all-cause and cardiovascular mortality in nondiabetic persons. J Intern Med. 2008; 264:493–501. PMID: 18624904.

12. Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, et al. Low-grade albuminuria and cardiovascular risk: what is the evidence. Clin Res Cardiol. 2007; 96:247–257. PMID: 17453140.

13. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005; 112:969–975. PMID: 16087792.

14. Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M, et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis. 2007; 49:208–216. PMID: 17261423.

15. Hong JW, Ku CR, Noh JH, Ko KS, Rhee BD, Kim DJ. Association between low-grade albuminuria and cardiovascular risk in Korean adults: the 2011-2012 Korea National Health and Nutrition Examination Survey. PLoS One. 2015; 10:e0118866. PMID: 25742159.

16. Chronic Kidney, Matsushita K, van der, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375:2073–2081. PMID: 20483451.

17. Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care. 2007; 30:701–706. PMID: 17327344.

18. Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015; 72:1–75. PMID: 26471080.

19. Gallagher PE, Li P, Lenhart JR, Chappell MC, Brosnihan KB. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension. 1999; 33(1 Pt 2):323–328. PMID: 9931124.

20. Elving LD, Wetzels JF, de Nobel E, Hoitsma AJ, Berden JH. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy. Am J Kidney Dis. 1992; 20:559–563. PMID: 1462982.

21. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997; 95:39–45. PMID: 8994414.

22. Lamb EJ, Tomson CR, Roderick PJ. Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry. Estimating kidney function in adults using formulae. Ann Clin Biochem. 2005; 42(Pt 5):321–345. PMID: 16168188.

23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143–3421. PMID: 12485966.

24. Blecker S, Matsushita K, Kottgen A, Loehr LR, Bertoni AG, Boulware LE, et al. High-normal albuminuria and risk of heart failure in the community. Am J Kidney Dis. 2011; 58:47–55. PMID: 21549463.

25. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991; 121(1 Pt 2):293–298. PMID: 1985385.

26. Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, et al. Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS One. 2013; 8:e83273. PMID: 24386169.

27. Xue B, Johnson AK, Hay M. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol Regul Integr Comp Physiol. 2013; 305:R459–R463. PMID: 23883676.

28. Roest M, Banga JD, Janssen WM, Grobbee DE, Sixma JJ, de Jong PE, et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation. 2001; 103:3057–3061. PMID: 11425768.

29. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989; 32:219–226. PMID: 2668076.

30. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation. 2001; 103:1869–1874. PMID: 11294805.

31. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol. 1995; 15:1324–1329. PMID: 7670945.

32. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol. 2006; 17:2106–2111. PMID: 16825333.